Richard (Ric) Hughen’s 30 years of professional experience in the life science industry span three startups, a mid-cap and three Fortune 500 companies. He is currently CEO of Cellth Systems, a startup based upon proprietary Circulating Tumor Cell (CTC) analysis technology. Ric’s background crosses diverse clinical fronts including interventional pulmonology, thoracic surgery, interventional cardiology, gastroenterology, ENT, oncology, orthopedics, gynecology, wound care, molecular diagnostics and health-IT. He is founder of Life Science Planning, a strategic consultancy for life science companies with focus on fast paced startup, early stage and emerging growth companies. Hughen was a member of the executive team that led startup CSA Medical from a technology license (Navy), through product development, clinical trials, five FDA clearances, CE mark, four rounds of funding ($50M) and into a profitable commercial business. Before CSA Medical, he directed the marketing efforts for the $210 million molecular diagnostics business of Becton, Dickinson (BD). Prior to BD, Hughen was managing director of an e-learning startup, LearnWare, which was successfully built and sold to a private equity fund. Hughen holds a bachelor’s degree and an MBA from The Pennsylvania State University.

When not working, he is typically outside training for triathlon competition or umpiring Little League baseball.